glp 1 agonisté Mechanisms of action of GLP-1RA Frontiers | GLP-1 Receptor Agonists:
Description
In particular, sDPP-4 acts as a direct mediator of endothelial dysfunction, probably through PAR2 activation and the induction of vasoconstrictor prostanoid release (e.g., thromboxane A2) [60]
Practical and economic considerations
the precise BMI cutoffs for children differ by age
Although these trials primarily enrolled individuals with relatively low DKD risk and were not designed to evaluate kidney outcomes specifically, exploratory analyses consistently indicated slower kidney disease progression across diverse eGFR and albuminuria levels [39-44]
